Dose-Response Relationship, RadiationUltraviolet RaysNeoplasmsUterine Cervical NeoplasmsRadiation DosageCarcinogensRadiation, IonizingRadiation InjuriesCell Transformation, NeoplasticAneuploidyRadiation ToleranceEarly Detection of CancerRadiationRadiation ProtectionRadiation MonitoringRisk AssessmentVaginal SmearsPapillomavirus InfectionsRisk FactorsPapanicolaou TestRadiation OncologyPapillomaviridaeCarcinoma, Squamous CellRadiotherapyNeoplasms, Radiation-InducedBreast NeoplasmsCombined Modality TherapyRadiotherapy DosagePapillomavirus VaccinesCervical Intraepithelial NeoplasiaCosmic RadiationNeoplasm InvasivenessHuman papillomavirus 16Radiation Injuries, ExperimentalOvarian NeoplasmsGamma RaysRadiation PneumonitisNeoplasm StagingRadiometryProstatic NeoplasmsMice, NudeGene Expression Regulation, NeoplasticLung NeoplasmsNeoplasm MetastasisPrognosisMass ScreeningCell Line, TumorColonic NeoplasmsAntineoplastic AgentsRetrospective StudiesSurvival AnalysisStomach NeoplasmsSurvival RateHuman papillomavirus 18Background RadiationFollow-Up StudiesRadiation-Sensitizing AgentsAntineoplastic Combined Chemotherapy ProtocolsBrachytherapyPancreatic NeoplasmsNeoplasm Recurrence, LocalCarcinomaAdenocarcinomaNeoplasm ProteinsCancer VaccinesDose FractionationCervix UteriRiskCell SurvivalDisease ProgressionProspective StudiesRadiation EffectsTreatment OutcomeTumor Markers, BiologicalCisplatinOncogene Proteins, ViralDisease-Free SurvivalUnited StatesSensitivity and SpecificityRadiotherapy, AdjuvantAge FactorsTumor Suppressor Protein p53ApoptosisRegistriesGenetic Predisposition to DiseaseTime FactorsPapillomavirus E7 ProteinsReverse Transcriptase Polymerase Chain ReactionTumor Virus InfectionsAlphapapillomavirusCarcinoma, Non-Small-Cell LungRadiation-Protective AgentsRNA, MessengerXenograft Model Antitumor AssaysDNA DamageRadiotherapy Planning, Computer-AssistedHead and Neck NeoplasmsMutationSurvivorsGene Expression Profiling